Investing in biotech companies requires a lot of faith and courage. It is not easy to risk assets into a stock on faith that their research will deliver viable results. This clearly makes ImmunoGen (NASDAQ:IMGN) a momentum stock. This makes it difficult to trade because on the way down, it...